Lavipharm S.A. (ATH:LAVI)
1.570
+0.004 (0.26%)
Aug 12, 2026, 5:19 PM EET
Lavipharm Market Cap
Lavipharm has a market cap or net worth of €267.44 million as of August 12, 2026. Its market cap has increased by 96.70% in one year.
Market Cap
267.44M
Enterprise Value
294.11M
Revenue
64.53M
Ranking
n/a
PE Ratio
52.45
Stock Price
€1.57
ChartMarket Cap Chart
Since October 21, 1996, Lavipharm's market cap has increased from 43.03M to 267.44M, an increase of 521.58%. That is a compound annual growth rate of 6.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 267.44M | 63.44% |
| Dec 31, 2025 | 163.63M | 22.01% |
| Dec 31, 2024 | 134.11M | 0.36% |
| Dec 29, 2023 | 133.62M | 107.29% |
| Dec 30, 2022 | 64.46M | 117.58% |
| Dec 31, 2021 | 29.63M | 23.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ideal Holdings | 328.46M |
| Noval Property Real Estate Investment Company | 328.08M |
| Bank of Greece | 295.99M |
| Intracom Holdings | 254.76M |
| Real Consulting | 247.83M |
| Evropi Holdings Societe Anonyme | 247.71M |
| Dimand | 241.82M |
| Trade Estates REIC | 240.23M |